HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: P41 GM103331
HHS | National Institutes of Health
Grant: R01 AI136680
HHS | National Institutes of Health
Grant: R01 AI146017
HHS | National Institutes of Health
Grant: U54 AI150472
NIGMS NIH HHS
Grant: P30 GM103331
NIGMS NIH HHS
Grant: U54 GM103368
NCI NIH HHS
Grant: P30 CA014195
National Institutes of Health
Grant: 5R01AI136680-05
Structural basis for activity of and resistance to HIV integrase inhibitors
National Institutes of Health
Grant: 7U54AI150472-10
HIV Interactions In Viral Evolution
National Institutes of Health
Grant: 4P30GM103331-05
MUSC Center for Oral Health Research
National Institutes of Health
Grant: 5R01AI146017-02
Novel mechanism of integrase (IN) resistance to Dolutegravir through epistatic interactions between IN and the nucleocapsid and polypurine tract regions of HIV-1
Margaret T. Morris Foundation
FWCI
0.53
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals